NEW YORK (GenomeWeb News) – Gen-Probe today said that the US Food and Drug Administration has granted an Emergency Use Authorization for the firm's Prodesse ProFlu-ST assay for use in CLIA high-complexity labs for diagnosis of 2009 H1N1 influenza virus infection.

The FDA granted the EUA for use of the test "aided by an algorithm that relies on seasonal influenza A/H1 virus and seasonal influenza A/H3 virus results, from a single sample in individuals who are diagnosed with influenza A by currently available FDA-cleared or authorized devices."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.